They are the worst at counterfeiting. I can see industrials, etc. , getting hit. Not selling, today maybe the day to add, see how it goes. Futures way down.
You have to get through the typical Wall Street manipulation, like they are shock a development stage biotech with numerous trials at various stages is losing money ploy.
JPM thinks its approvable now.They added 100+ patients so the effect of the drug is skewed to a lower response rate.IMHO.
I think it will too. Typical shake out before conference to scare folks out of their shares. Low volume today and yesterday, squeezing out remaining sellers, which will make a bigger pop.
Depends what time frame, results good, New highs, for sure, could rip like Blue $180--$200 in a couple of months. Ok results languish here, not so good down side 10-25%IMHO
The astute do know the potential, nirvana potential outcome. I bought more today, and will keep buying this gem. Thanks again Leo and management team....!!!!
It also opens the door for a buyout of AGIO. Celg doesn't have to decide which one now. Puma kind of gave insight that the CART-T maybe overhyped...now back to the real potential cure for cancer.